These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 34358364)
1. Tricyclic antidepressant-induced photosensitivity; A case report and systematic review. Boontaveeyuwat E; Steyn M; Rickaby W; Mcfadden JP; Sarkany RPE; Fityan A Photodermatol Photoimmunol Photomed; 2022 Mar; 38(2):112-122. PubMed ID: 34358364 [TBL] [Abstract][Full Text] [Related]
2. Amitriptyline-induced cutaneous hyperpigmentation: case report and review of psychotropic drug-associated mucocutaneous hyperpigmentation. Eichenfield DZ; Cohen PR Dermatol Online J; 2016 Feb; 22(2):. PubMed ID: 27267189 [TBL] [Abstract][Full Text] [Related]
3. Novel hyperpigmentation pathophysiology following a prolonged course of imipramine therapy. McKenna B; Wold L; Noland MM; Schenck O J Cutan Pathol; 2024 Feb; 51(2):105-107. PubMed ID: 37818708 [TBL] [Abstract][Full Text] [Related]
4. Photoinduced dermal pigmentation in patients taking tricyclic antidepressants: histology, electron microscopy, and energy dispersive spectroscopy. Sicari MC; Lebwohl M; Baral J; Wexler P; Gordon RE; Phelps RG J Am Acad Dermatol; 1999 Feb; 40(2 Pt 2):290-3. PubMed ID: 10025850 [TBL] [Abstract][Full Text] [Related]
5. Imipramine-Induced Cutaneous and Iris Hyperpigmentation: A Case Report and Literature Review. Coffey N; Ali Z; Grau J Prim Care Companion CNS Disord; 2022 Mar; 24(2):. PubMed ID: 35364629 [No Abstract] [Full Text] [Related]
6. Photodistributed blue-gray pigmentation of the skin associated with long-term imipramine use. Angel TA; Stalkup JR; Hsu S Int J Dermatol; 2002 Jun; 41(6):327-9. PubMed ID: 12100685 [TBL] [Abstract][Full Text] [Related]
7. Imipramine-induced hyperpigmentation: a case report and review of the literature. D'Agostino ML; Risser J; Robinson-Bostom L J Cutan Pathol; 2009 Jul; 36(7):799-803. PubMed ID: 19519613 [TBL] [Abstract][Full Text] [Related]
8. Imipramine-induced hyperpigmentation: four cases and a review of the literature. Ming ME; Bhawan J; Stefanato CM; McCalmont TH; Cohen LM J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):159-66. PubMed ID: 10025739 [TBL] [Abstract][Full Text] [Related]
9. Imipramine-induced facial pigmentation: case report and literature review. Metelitsa AI; Nguyen GK; Lin AN J Cutan Med Surg; 2005 Dec; 9(6):341-5. PubMed ID: 17016757 [TBL] [Abstract][Full Text] [Related]
10. Laser treatment of imipramine-induced hyperpigmentation. Atkin DH; Fitzpatrick RE J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):77-80. PubMed ID: 10863228 [TBL] [Abstract][Full Text] [Related]
17. Acrocyanosis as a side effect of tricyclic antidepressants: a case report. Karakaya I; Aydoğan M; Coşkun A; Gökalp AS Turk J Pediatr; 2003; 45(2):155-7. PubMed ID: 12921305 [TBL] [Abstract][Full Text] [Related]
18. Utilization patterns of tricyclic antidepressants in a multidisciplinary pain clinic: a survey. Richeimer SH; Bajwa ZH; Kahraman SS; Ransil BJ; Warfield CA Clin J Pain; 1997 Dec; 13(4):324-9. PubMed ID: 9430813 [TBL] [Abstract][Full Text] [Related]
19. Quantification of Tricyclic Antidepressants in Serum Using Liquid Chromatography Electrospray Tandem Mass Spectrometry (HPLC-ESI-MS/MS). Crutchfield CA; Breaud AR; Clarke WA Methods Mol Biol; 2016; 1383():265-70. PubMed ID: 26660194 [TBL] [Abstract][Full Text] [Related]
20. Recurrence of dilated cardiomyopathy after re-introduction of a tricyclic antidepressant. Briec F; Delaire C; Bouhour JB; Trochu JN Arch Mal Coeur Vaiss; 2006 Oct; 99(10):933-5. PubMed ID: 17100146 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]